University of Hawai‘i at Manoa Homepage

Faculty

Clayton D. K. Chong, MD, MPH

Clayton D. K. Chong, MD, MPH
  • Clinical Member
    Cancer Epidemiology Program
    University of Hawaii Cancer Center
  • Academic Appointments

  • Associate Clinical Professor
    University of Hawaii Cancer Center
    University of Hawaii at Manoa
  • Assistant Clinical Professor
    Department of Medicine
    John A. Burns School of Medicine
    University of Hawaii at Manoa

Degree

  • MD, Medicine
    John A. Burns School of Medicine Honolulu, HI
  • Internship & Residency, Medicine
    John A. Burns School of Medicine Honolulu, HI
  • Fellowship, Oncology
    University of Texas MD Anderson Cancer Center Houston, TX
  • MPH
    Harvard School of Public Health Boston, MA

Research Focus

My career in medical oncology spans 25 years with a focus on cancer health disparities among Native Hawaiians, the indigenous population of Hawai'i. I am a clinical medical oncologist in private practice and also serve as Medical Director of the Queen's Medical Center Cancer Center, the largest community hospital in the state, treating the largest proportion of cancer patients (40%) annually. Since its inception in 2000, I have been the Principal Investigator for 'Imi Hale, Native Hawaiian Cancer Network (UO1 CA114360/U54CA153459) and have dual roles at the University of Hawai'i as a teaching professor with the John A Burns School of Medicine and as an Associate Professor with the University of Hawaii Cancer Center with a concentration in Oncology health disparities research. 'Imi Hale is one of 23 NCI Community Network Program Centers with a primary focus on reducing cancer health disparities among Native Hawaiians using community-based participatory research methods to develop and conduct competitive research. I have pursued genetic profiling of breast cancer in Native Hawaiian women to better understand the disparate breast cancer incidence and mortality in Hawaiian women and this proposal builds on past and current studies, including a current ARRA grant award (CA071789-12S6) which expands my focus in genetic profiling of breast cancer to multiethnic populations in Hawai'i. Through the community participatory research efforts of 'Imi Hale and the research supported through the ARRA grant, I am able to pursue a translational approach to healthcare disparities among Native Hawaiians. I support this study to encourage physical activity among breast cancer survivors, particularly a mode that is culturally relevant to many women in the state of Hawaii.

Selected Publications

  • Hernandez BY, Wilkens LR, Le Marchand L, Horio D, Chong CD, Loo LWM. (2015). Differences in IGF-axis protein expression and survival among multiethnic breast cancer patients. Cancer Med, 4(3):354-62.
  • Shen Y, Katsaros D, Loo LWM, Hernandez BY, Chong C, Canuto EM, Biglia N, Lu L, Risch H, Chu W-M, Yu H. (2015). Prognostic and predictive values of long non-coding RNA LINC00472 in breast cancer. Oncotarget, 6(11):8579-8592.
  • Chong CDK, Loo L, Wilkens L, Caberto C. (2011). High relapse rates and poor survival of Native Hawaiian (NH) women with HER2-positive breast cancer, J Clin Oncol, 29: 2011 (suppl; abstr e11116).
  • Braun KL, Tsark JU, Santos LA, Aitaoto N, Chong C. (2006). Building Native Hawaiian capacity in cancer research and programming. Cancer 107(8 Suppl), 2082-2090. PMID: 16977599.
  • Braun K, Fong M, Gotay C, Chong C. (2005). Ethnicity and Breast Cancer in Hawaii: Increased survival, but continued disparity. Ethnicity and Disease, 15(3):453-460. PMID: 16108306.
  • Braun K, Fong M, Gotay C, Chong C. (2004). Ethnic differences in breast cancer in Hawaii: age, stage, hormone receptor status, and survival. Pacific Health Dialog, 11(2):146-153. PMID:16281692.

Publication list via PubMed

Active Grants

  • C. Chong & K. Braun, Co-PIs
    U54 CA153459
    " 'Imi Hale Native Hawaiian Cancer Network Program- Community Network Program Center II" The primary focus is to reduce cancer health disparities among Native Hawaiians through the establishment of a sustainable infrastructure to increase knowledge of, access to, and use of beneficial biomedical procedures in cancer prevention and control and co-morbid conditions of cancer patients; develop and conduct evidence-based intervention research to increase use of beneficial biomedical procedures to control cancer, and train and develop competitive research using CBPR methods to reduce cancer health disparities.
    09/01/10 - 08/31/15